Atherosclerosis  Technologies of Personalized Medicine 

<br/><br/><br/>English[eng] 
<br/><br/><label>ISBN: </label>9783040000000 
<br/><br/><label>Subjects--Topical Terms: </label><br/>metalloproteinases||calcification||atherosclerosis||multiplex assay||coronary heart disease||aspirin||resistance||non-sensitivity||antiplatelet||light transmission aggregometry||Plateletworks®||familial hypercholesterolemia||targeted sequencing technologies||multiplex ligation-dependent probe amplification||LDLR||APOB||ABCG5||APOC3||LPL||SREBF1||rare variants||coronary atherosclerosis||ischemic heart disease||saturated fatty acids||monounsaturated fatty acids||polyunsaturated fatty acids||oxidative stress||superoxide dismutase||catalase||glutathione peroxidase||cumulative LDL-C level||prognosis||DNA methylation||epigenetic age||myocardial infarction||acute coronary syndrome||population||nested case-control||HAPIEE project||HAPIEE study||atrial fibrillation||arterial hypertension||obesity||diabetes mellitus||aging||determinants||prevalence||Russian population cohort||Cox regression analysis||adiponectin||leptin||interleukin-6||epicardial adipose tissue||perivascular adipose tissue||circulating biochemical markers||coronary atherosclerosis presence and severity||integrated biomarker (i-BIO)||validation||visual markers||lipoprotein(a)||immune cells blood count||n/a